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Substrate-carbon oxidation by isolated rat glomeruli
in aminonucleoside nephrosis
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Substrate-carbon oxidation by isolated rat glomeruli in amino-
nucleoside nephrosis. The oxidation of several substrates by
isolated glomeruli was measured at various times after the
administration of aminonucleoside of puromycin (AP) to rats as
a single i.p. injection. A significant decrease in uniformly
labelled 14C-glucose (glucose-U-'4C) oxidation occurred after 7
days and returned to control values by 14 days. Rats studied
1, 3,4, 7 and 14 days after AP administration excreted 4.5, 10.5,
131. 259 and 180 mg of protein/24 hr, respectively. On day 1
there was no difference in glucose-U-'4C oxidation between
control and experimental rats; on day 3 there was a decrease in
glucose-carbon oxidation and on days 4 and 7 the decrement was
very significant. There was, thus, a progressive decrease in
glucose-carbon oxidation with increasing proteinuria during the
first week. A decrease in alanine-U-14C oxidation was found 7
and 14 days after AP injection was given. Studies using other
substrates were done seven days after AP injection with the
following results: a decrease in pyruvate-carbon and glutamine-
U-'4C oxidation, no change in acetate-carbon and citric-6-14C
acid oxidation and an increase in citric-I ,5-14C acid oxidation.
Therefore, AP induces complex changes in substrate-carbon
oxidation by isolated glomeruli and, by inference, in the cells
which produce the glomerular basement membrane or maintain
its molecular integrity or both. These biochemical alterations
may in part be responsible for the increased permeability of this
membrane to protein in AP nephrosis.
Oxydation du carbone de divers substrats par les glomérules
isolés de rat atteints de néphrite de l'aminonucléoside. L'oxydation
de divers substrats par les glomérules isolés a été mesurée des
délais variables après l'administration d'aminonucléoside de
puromycine (AP) a des rats sous Ia forme d'une injection
intrapéritonéale unique. Une diminution significative de
l'oxydation du glucose-U-'4C survient au 7e jour, le retour aux
valeurs normales est obtenu au 1 4e jour. Les rats étudiés 1, 3, 4,
7 et 14 jours aprés AP excrètent respectivement 4,5; 10,5; 131;
259 et 180 mg de protéines par 24 heures. Au premier jour il n'y
a pas de difference dans l'oxydation du glucose-U-14C entre les
animaux contrôles et expérimentaux; au 3e jour ii apparait une
diminution de l'oxydation du carbone du glucose; au 4e et 7e
jours cette diminution est trés significative. Ainsi, pendant la
premiere semaine, il existe une diminution progressive de
l'oxydation du carbone du glucose alors que Ia protéinurie
augmente. Une diminution de l'oxydation de l'alanine-U-14C
est observée entre les 7e et 14e jours consécutifs a l'injection
d'AP. Des etudes utilisant d'autres substrats ont été réalisées
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sept jours après l'injection d'AP et donnent les résultats suivants:
diminution de l'oxydation du carbone du pyruvate et de Ia
glutamine-U-14C, absence de modification de l'oxydation du
carbone de l'acétate et de l'acide citrique-6-14C, augmentation
de l'oxydation de l'acide citrique-1 ,5-14C. L'AP induit done des
modifications complexes de l'oxydation par les glomérules isolés
du carbone des substrats et, par consequent, dans les cellules qui
produisent Ia membrane basale glornérulaire et/ou maintiennent
son intégrité moléculaire. Les alterations biochimiques sont en
partie responsables de la perméabilité de cette membrane aux
protéines dans la néphrite AP.
Although the sequence of events which leads to the
development of proteinuria in aminonucleoside of
puromycin (AP) nephrosis [1, 2] is not completely
known, the basic defect appears to be increased
glomerular basement membrane (GBM) permeability
to protein as demonstrated by electron microscopic
studies using ferritin [3] and lanthanum [4]. This
GBM alteration may occur at or near a molecular
level since no abnormalities have been demonstrated
by light, immunofluorescent or electron microscopy
to account for the proteinuria.
Information on the biochemical properties of the
GBM can be obtained from studies of its chemical
composition, synthesis and degradation, and in-
directly from the metabolism of the cells which
produce and maintain it. Changes in the utilization of
substrates [5—7] and differences in enzyme activity
[8, 9] in renal cortical and medullary slices have been
reported in the AP model. However, since the studies
on substrate utilization were done on cortical
slices, and because conflicting results were obtained
[5, 101, it seemed appropriate to investigate the meta-
bolism of isolated glomeruli from rats with AP
nephrosis. This could permit the quantification of
changes which might relate more directly to those
cells which produce and/or maintain the GBM.
Therefore, this study was designed to investigate the
oxidation of several substrates, as indexes of glomeru-
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lar metabolism, by isolated glomeruli from rats with
AP nephrosis.
Methods
Glomerular isolation [11]. Rats were anesthetized by
the i.p. injection of sodium phenobarbital in a dose of
10 mg/100 g. The abdomen was opened by a large
V-incision extending into the left thorax, and the
thoracic aorta was exposed, cannulated and ligated
proximally. The abdominal viscera were clamped,
the left renal vein was incised and the kidneys were
perfused with 60 to 100 ml of ice cold oxygenated
Krebs-Ringer phosphate buffer (glucose, 10 mmoles/
liter; pH 7.3). The capsule of the kidney was re-
moved, the kidneys were halved and the medulla was
dissected out. The cortices were minced finely with a
razor blade and gently buttered through a 180-mesh
sieve. The tissue thus obtained was thoroughly sus-
pended in 30 ml of buffer by syringing through a size
18 needle at least five times. Glomeruli were then
separated from the tubules and other debris by
centrifugation at 120 x G for 90 sec. The supernatant
was removed by suction and discarded and the pellet
was resuspended in 30 ml of the buffer. The tissue was
centrifuged and the pellet resuspended seven times.
Two glomerular preparations were obtained from each
rat. Preparations less than 95% pure were discarded.
Incubation of glomeruli. The glomerular preparation
from each kidney was suspended in 0.9 ml of the
Krebs-Ringer phosphate solution and this was added
to 100 l of the 14C substrate dissolved in Krebs-
Ringer phosphate buffer.
The incubation was carried out in a 10-ml tube (A)
(Vacutainer, Becton-Dickinson, Division of Becton,
Dickinson & Co., Rutherford, NJ). Oxygen (100%)
was passed through inlet and exit needles in the stopper
of tube A for three minutes at 4 liters/mm. The sus-
pension was then incubated at 37°C while being shaken
in a water bath at 110 cycles/mm for three hours. At
the end of this period, tube A was connected via a
clamped-off blood-taking unit (Becton-Dickinson)
to a second 10-mI tube (B) (Vacutainer) to which
had been added 0.5 ml of hydroxide of Hyamine
(Packard Instrument Co. Inc., La Grange, IL). The
vacuum was still present in tube B. The clamp was
removed and 0.2 ml of iN HC1 was injected into tube
A. After a one- or two-hour equilibration period at
room temperature, the radioactivity of the trapped
'4C02 was counted in a liquid scintillator (Unilux II,
Nuclear-Chicago Corp., Des Plaines, IL) for ten
minutes at an efficiency of 77%. The scintillation
mixture consisted of 4 g of 2,5-diphenyloxazole
(PPO) and 0.5 g of 1,4-bis-2-(5-phenyloxazole) ben-
zene (POPOP) made up to a final volume of 1000 ml
in toluene.
Deoxyribonucleic acid (DNA) content of the
glomeruli was determined as follows [121: Distilled
water, 0.8 ml, was added to the glomerular suspension
and this was transferred from tube A into a 50-ml
incubation tube after the equilibration with Hyamine
had been completed. This 50-ml tube was vigorously
agitated and then to it were added, in sequence, 1 ml
of 0.04% indole and 1 ml of concentrated hydrochloric
acid. The mixture was shaken thoroughly, heated for
ten minutes in a water bath at 100°C, cooled under
tap water and extracted and centrifuged three times
with highly purified chloroform. The yellow super-
natant was read at 490 s in a spectrophotometer
(Coleman Junior, Coleman Instruments, Maywood,
IL). Standard curves prepared using purified calf
thymus DNA extract (Calf Thymus I, Sigma Chemical
Corp., St. Louis, MO) were linear from 12 to 96
of DNA/ml. The recovery of DNA added to
glomerular suspensions was 90% (83 to 98%).
Substrates. Uniformly labelled substrates—D-glu-
cose-U-'4C, L-alanine-U-'4C—pyruvate- 1 -'4C, sodium
acetate 1-'4C, citric-6-'4C acid, citric-1-5-4C acid and
L-glutamine-14C were used (New England Nuclear,
Boston, MA). Each 14C substrate was dissolved in
Krebs-Ringer phosphate buffer containing 10 mmoles/
liter of glucose. In addition, the Krebs-Ringer
phosphate buffer contained 10 mmoles/liter of L-
alanine, sodium pyruvate, sodium acetate, citric acid
or L-glutamine for the experiments in which alanine-
carbon, pyruvate-carbon, acetate-carbon, citrate-
carbon or glutamine-carbon oxidation was studied.
Substrate-specific activities are listed in Table 1.
Urinary protein concentration was measured by a
sulfosalicylic acid method. Serum protein concentra-
tion was measured by the biuret method and serum
cholesterol concentrations were determined by an
Autoanalyser system (Technicon Instrument Corp.,
Tarrytown, NY) in the animals from experiment 2.
Calculations. The results of substrate-carbon oxida-
tion were expressed as mmoles of substrate oxidized
to C02/mg of DNA/three hours; the formula used in
this calculation was as follows:
mimoles of substrate-carbon oxidized to C02/mg of
glomerular DNA content/three hours =
sample dpm —blank dpm
substrate-specific activity
(dpm/mimoles of substrate carbon)
1X
glomerular DNA (mg)
Statistical significance was determined by Student's t
test.
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Table 1. Substrate-specific activities
Substrate Specific activity
,nC!/mmoles' pCi/1.O pmoles' dpm/mmoles0
o-glucose-14C 4.8 0.5 18.0
L-alanine-14C 128.0 0.5 36.0
Sodium pyruvate-1-14C 5.85 1.0 72.0
Sodium acetate-1-14C 2.2 1.0 110.0
Citric-6-'4C acid 6.68 0.5 36.0
Citric-1,5-'4C acid 9.4 0.5 36.0
L-glutamine-14C 256.0 2.5 92.0
a Specific activity as supplied by manufacturer.
Specific activity of the substrate-carbon in 0.1 ml of the incubation medium before being added to
0.9 ml of the glomerular suspension.
Specific activity of substrate-carbon in the incubation medium expressed as dpm/mmo1es of
substrate-carbon.
In order to test the validity of using glomerular
DNA content as the denominator in the calculation,
12 studies were done comparing the DNA content
with the number of glomeruli from control and experi-
mental rats. Glomeruli suspended in 1 ml of buffer
were agitated to assure uniform distribution. The
DNA content was determined in 0.9 ml, and the
number of glomeruli in 0.1 ml was counted. The
regression coefficients of these values were r=0.94
for control and r=0.86 for experimental studies. A
positive correlation was thus found between the
number of glomeruli and the DNA content in both
control and experimental studies.
Experimental design
Control and experimental male hooded rats
(Canadian Breeding Farms, Laval, Quebec, Canada)
weighing 130 to 180 g were fed rat chow (Purina) and
water. Free access to water only was allowed for the
24 hr before the glomeruli were isolated, and during
this 24-hr period urine was collected in metabolism
units (Econo, Canlab, Montreal, Quebec, Canada).
Aminonucleoside of puromycin (Nutritional Bio-
chemical Corp., Cleveland, OH) was dissolved in
20 ml of sterile water to a final concentration of
5 mg/mi. Experimental rats received AP in a dose of
15 mg/lOO g i.p. Control rats were given an injection
of distilled water and were studied with each experi-
mental group.
Experiment 1. Sixty rats were divided into two
groups for this experiment and were studied 7 and 14
days after the injection of AP or water. These incuba-
tion studies were performed with D-glucose-U-'4C.
'4C02 was absorbed for two hours by Hyamine in this
experiment and in experiment 3.
Experiment 2. Sixty rats were divided into four
groups and studied one, three, four and seven days
after the AP or water injection. D-glucose-U-14C was
used in these incubation studies and '4C02 was
absorbed for one hour by Hyamine in this experiment
and experiment 4.
Experiment 3. Thirty rats were studied 7 and 14 days
after injection of AP. The glomerular suspensions
frem these rats were incubated with L-alanine-U-14C.
Experiment 4. One hundred rats were used in this
experiment and studied seven days after AP or water
injection. Glomeruli isolated from these were incu-
bated with the following substrates: sodium acetate- 1-
'4C, sodium pyruvate-l-14C, citric-6-14C acid, citric-I,
5-'4C acid or L-glutamine-U-14C.
Results
Urine and serum. The mean urine protein excretion
was under 5 mg/24 hr for all control rats. In experi-
ment 1 the urine protein excretion was 200 and
180 mg/24 hr on days 7 and 14, respectively. The mean
urine protein values in experiment 3 rose from 4.5 mg/
hronday ito 10.5 mg/24hronday3, 131 mg/24hron
day 4 and 259 mg/24 hr on day 7.
In experiment 2 the total serum protein concentra-
tion decreased from 5.8 in controls to 3.5 and 4.7 g/
100 ml on days 7 and 14, respectively. The serum
cholesterol concentration rose from a control value
of 93 to 381 and 407 mg/lOO ml on days 7 and 14,
respectively.
Rat weights. Rats injected with AP in a dose of
15 mg/100 g failed to gain weight at the same rate as
controls. By day 7 the experimental animals had lost
an average of 4 g while the controls gained 13 g; by
day 14 the experimental rats had gained 21 g and the
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Table 2. Results of substrate-carbon oxidation seven days after a single i.p. injection of AP
Substratea Control SEM (N) Experimental SEM (N) P value
Sodium pyruvate-1-14C 3117 260 (16) 1890 163 (14) <0.001
Sodium acetate-l-14C 77 6 (8) 70 5 (8) >0.5
Citric-6-'4C acid 109 7.7 (16) 112 6 (16) >0.5
Citric-l,5-14C acid 833 62 (16) 1170 61 (16) <0.001
L-glutamine-U-'4C 390 27 (14) 268 14 (14) <0.001
a Results expressed in mtmoles of substrate-carbon oxidized to C02/mg of DNA/three hours.
controls had gained 40 g. All the experimental rats
had ascites and enlarged pale kidneys by day 7.
Ascites was no longer present by day 14.
Results of '4C substrate oxidation. There was de-
creased oxidation of glucose-carbon to C02/mg of
DNA/three hours on day 7 but no difference between
control and experimental values on day 14 (Fig. 1).
This was a consequence of a return to normal levels
by day 14, not a drop in control values. The rates of
glucose-carbon oxidation on days 1, 3, 4 and 7 (Fig. 2)
were as follows: day 1, no reduction; day 3, a slight
decrease (P <0.05); days 4 and 7, significant reductions
with P values of <0.01 and <0.001, respectively.
Alanine-carbon oxidation was studied in control,
day-7 and day-14 animals. Significant reductions were
found on days 7 (P<0.01) and 14 (P < 0.001) (Fig. 3).
In the remaining experiments, the studies were done
on day 7 (Table 3). The rates of substrate-carbon
oxidation for experimental animals were as follows:
Control
Experimental
Day 1 3 4 7
N 1315 1216 1313
P >0.5 <0.05 <0.01
Control
Experimental
-
c-)
V
68
<0.001
Fig. 2. Glucose-carbon oxidized to C02/mg of DNA/three hours in
control and experimental rats one, three, four and seven days after
one i.p. injection of aminonucleoside. Brackets indicate I sn.
400.
200
0
N 18 17 10
P <0.02 <0.001
Fig. 3. Alanine-carbon oxidation to C02/mg of DNA/three hours
in control rats and in experimental rats 7 and 14 days after a single
i.p. injection of aminonucleoside. Brackets indicate one standard
deviation.
c_)
N 88
P <0.02
Fig. 1. Glucose-carbon oxidized to C02/mg of DNA/three hours
in control and experimental rats 7 and 14 days after a single dose of
aminonucleoside injected i,p. Brackets indicate I SD.
Day 7 14
68
>0.5
Controls Day 7 Day 14
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Table 3. Summary of studies on carbohydrate metabolism in rats with AP nephrosis'
Tissue Experiment Day Result Reference
Isolated glomeruli Quantitative histochemistry Increased glucose-6-phosphate dehydrogenase,
lactate dehydrogenase and malic dehydrogenase
activity
8
Cortex slices Histochemical studies of
enzymes
8
9—13
Increase in DPN-dependent activity
Increase in TPN-linked enzymes
Increase in TPN-diaphorase, DPN-dependent
enzymes
Increase in glucose-6-phosphate dehydrogenase
9
Cortex slices Enzyme activities 7—10 Decreased glutamic pyruvic transaminase and
condensing enzyme activities
14
Cortex slices 02 uptake and gluconeogenesis No inhibition of endogenous respiration
Inhibition of respiratory responses to added
pyruvate of succinate
Gluconeogenesis was also inhibited
6
Cortex slices Gluconeogenic capacity(substrates used were
c-ketog1utarate, pyruvate,
succinate)
24 hr
7
Inhibition of gluconeogenesis
Further inhibition
7
Cortex slices 02 consumption using
glucose, fructose, succinate
and D-alanine as substrates
6—16 Decreased 02 consumption 5
Cortex slices Enzyme activity
02 consumption using
glucose as the substrate
Anerobic glycolysis
No change in glutamic-pyruvic transaminase or
glutamic-oxaloacetic transaminase activity
No change
No change
10
DPN, diphosphopyridine nucleotide; TPN, triphosphopyridine nucleotide.
pyruvate-carbon, decreased (P <0.001); sodium ace-
tate-carbon, no change (P>0.5); citric-6-14C acid, no
change (P>0.5); citric-1,5-'4C acid, a significant
increase (P<0.001); and glutamine-carbon, signifi-
cantly reduced (P <0.001).
Discussion
The basic abnormality leading to proteinuria in AP
nephrosis appears to be increased permeability of the
GBM to proteins, possibly due to a functional
rearrangement of the molecules within the GBM [131.
The rationale for studying the metabolism of isolated
glomeruli from rats with experimental nephrotic syn-
drome is based on the assumption that an alteration
in the alignment or composition of the molecular
structure of the GBM is preceded by, or accompanied
by, changes in the biochemical functions of the cells
which maintain the membrane. It is possible that some
of these changes can be measured by studying indices
of glomerular metabolism such as cellular oxidation of
various substrates. A quantitation of aspects of the
metabolism of isolated glomeruli includes by inference
the metabolic activity of the cells which are in contact
with the GBM.
The studies to date of changes in glomerular meta-
bolism induced by AP can be divided into four main
categories: 1) the assessment of alterations in carbo-
hydrate enzymes as determined by histochemical
techniques [8, 9, 14]; 2) the effect on substrate utiliza-
tion by cortical slices [5—7, 101 (Table 3); 3) the meas-
urement of changes in the composition and turnover
of the GBM; and 4) histochemical and chemical
studies on changes in glomerular sialoprotein and
sialic acid content induced by AP [15—20].
A variety of results have been obtained in studies of
carbohydrate metabolism of renal cortical slices from
rats with AP nephrosis. One group of investigators
found reduced 02 consumption by slices incubated
with glucose [5] and a second group found that the
respiratory responses to added pyruvate or succinate
by kidney cortex slices from AP nephrotic rats were
inhibited at an unspecified time [6]. Gluconeogenesis
was inhibited within 24 hr of AP administration with
further inhibition on the seventh day after a single i.v.
injection of AP [7]. A third study reported no changes
in glycolysis [10]. In the present study, decreased
glucose-carbon oxidation was found four days after
the administration of 15 mg of AP/100 gas a single i.p.
injection to rats. This coincided with an increment in
the excretion of protein from 10.5 mg/24 hr on day 3
to 131 mg/24 hr on day 4. On day 7 a further slight
decrease was found in glucose-carbon oxidation, but
by day 14 the rate had returned to control values. Thus,
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although the decrement in glucose-carbon oxidation
was initially associated with an increase in proteinuria,
this returned to control values despite continuing
proteinuria, suggesting that changes in glucose-
carbon oxidation and proteinuria are independent,
parallel consequences of AP administration and that
no cause and effect relationship can be defined between
glomerular metabolism (using substrate-carbon oxida-
tion as the index) and proteinuria.
Although glucose-carbon oxidation returned to
control values on day 14, the oxidation of alanine-
carbon which was reduced by day 7 decreased even
further by day 14. According to some authors, alanine
is not utilized as a glucose precursor in the kidney
because of the absence, low concentrations, or
inactivity of glutamic-pyruvic transaminase [21, 221.
However, a reduction in the activity of this enzyme has
been reported in the kidneys of weanling rats between
seven and ten days after daily AP injections [14].
We found no uniform pattern of changes in the
oxidation of various substrates seven days after AP
administration at a time when there was marked
proteinuria. The oxidation of L-glutamine, L-alanine
and sodium pyruvic-1-14C acid decreased significantly,
but no change was found when sodium acetate-l-14C
was used as the substrate. By contrast, an increase with
citric-1,5-'4C acid was found although there was no
change in the oxidation of citric-6-'4C acid. These
findings reflect complicated changes in citric acid
cycle activity.
Although the events leading to these changes
appear to be initiated within 15 mm of AP administra-
tion [23], they can be detected only after several days
pan passu with increasing proteinuria. It is therefore
possible that these metabolic alterations are unrelated
concomitants of the proteinuria; on the other hand,
they may be important events in the pathogenesis of
the membrane defect. By inhibiting energy production
from substrate oxidation, AP may reduce the ability
of the glomerular cells to maintain the normal bio-
chemical structure of the GBM. Consequently,
synthesis or degradation of the GBM and its com-
position or structure may be subtly altered, and
increased permeability to protein may ensue.
The occurrence of these two demonstrable pheno-
mena, proteinuria and alterations in glomerular
substrate-carbon oxidation, may well be synchron-
istic and not causally related events. Further studies
are required to establish the nature of the relationship,
if any, between these changes.
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